| CRISPR Medicine | This is an overview of our news stories
Spatial Perturb-seq enables pooled in vivo CRISPR screening with single-cell, whole-transcriptome readouts preserved within intact tissue...
Some of the best links we picked up around the internet
The US FDA has issued a Study May Proceed notification for PBGENE-DMD, Precision BioSciences' investigational in vivo gene-editing therapy for...
A study published last week in Cell Stem Cell demonstrates for the first time that a topical, lipid nanoparticle-based gene editing approach can...
A UK and Korean study has developed a machine learning pipeline that integrates single-cell RNA sequencing with CRISPR screens and protein network...
On 28 January 2026, nChroma Bio dosed the first participant in its Phase 1/2 clinical trial of CRMA-1001, an investigational CRISPR-Cas-based...
